S. Duman Et Al. , "A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone," EUROPEAN RADIOLOGY , 2023
Duman, S. Et Al. 2023. A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone. EUROPEAN RADIOLOGY .
Duman, S., Kuru, D., Gumussoy, M., KİREMİTCİ, S., GÖKCAN, H., Ulas, B., ... Ellik, Z.(2023). A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone. EUROPEAN RADIOLOGY .
Duman, SERKAN Et Al. "A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone," EUROPEAN RADIOLOGY , 2023
Duman, SERKAN Et Al. "A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone." EUROPEAN RADIOLOGY , 2023
Duman, S. Et Al. (2023) . "A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone." EUROPEAN RADIOLOGY .
@article{article, author={SERKAN DUMAN Et Al. }, title={A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone}, journal={EUROPEAN RADIOLOGY}, year=2023}